Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Respiratory depression with remimazolam vs propofol in non-intubated general anesthesia for breast surgery
ChiCTR2400089826Phase 4Not yet recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypopnea, postoperative nausea and vomiting (PONV) and postoperative delirium (POD) comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Respiratory depression. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hypopneapostoperative nausea and vomiting (PONV)postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400089826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089826.